The Neurological Masquerade of Intravascular Lymphomatosis
Arch Neurol 59:439-443, Beristain,X.&Azzarelli,B., 2002
Subarachnoid Hemorrhage
Stroke 33:1321-1326, Kissela,B.M.,et al, 2002
Hemodynamic Studies in Early Ischemic Stroke
Stroke 33:1274-1279, Akopov,S. &Whitman,G.T., 2002
Thrombolytic Therapy Within 3 to 6 Hours After Onset of Ischemic Stroke
Stroke 33:1437-1441, Ringleb,P.A.,et al, 2002
Sickle Cell Disease: The Neurological Complications
Ann Neurol 51:543-552, Prengler,M.,et al, 2002
Functional Brain Mapping of Psychopathology
JNNP 72:432-439, Honey,G.D.,et al, 2002
Application of the New McDonald Criteria to Patients with Clinically Isolated Syndromes Suggestive of Mulitple Sclerosis
Ann Neurol 52:47-53, Dalton,C.M.,et al, 2002
Lacunar Stroke Is the Major Cause of Progressive Motor Deficits
Stroke 33:1510-1516,1443, Steinke,W. &Ley,S.C., 2002
Predictors of Hemorrhagic Transformation After Intravenous Recombinant Tissue Plasminogen Activator
Stroke 33:2047-2052, Selim,M.,et al, 2002
Risk Factors for Aneurysmal Subarachnoid Haemorrhage: the Tromso Study
JNNP 73:185-187,112, Isaksen,J.,et al, 2002
Progressive Ventricular Enlargement in Patients with Clinically Isolated Syndromes is Associated with the Early Development of Multiple Sclerosis
JNNP 73:141-147, Dalton,C.M.,et al, 2002
Association Between Subarachnoid Hemorrhage Outcomes and Number of Cases Treated at California Hospitals
Stroke 33:1851-1856, Bardach,N.S.,et al, 2002
Lesions of the Corpus Callosum: MR Imaging and Differential Considerations in Adults and Children
AJR 179:251-257, Bourekas,E.C.,et al, 2002
Blood Pressure Control in Stroke Patients
Neurol 59:23-25, Messerli,F.H.,et al, 2002
Is a "Vanishing Tumor" Always a Lymphoma?
Neurol 59:762-764, Bromberg,J.E.C.,et al, 2002
Neurological Presentation of Fabry's Disease in a 52 Year Old Man
JNNP 73:340-342, Mohanraj,R.,et al, 2002
Polycythemia Mimicking Venous Sinus Thrombosis
AJNR 23:1402-1403, Healy,J.F.&Nichols,C., 2002
CSF Evaluation in Primary CNS Lymphoma Patients by PCR of the CDR III IgH Genes
Neurol 58:390-396,339, Gleissner,B.,et al, 2002
A Longitudinal Study of Abnormalities on MRI and Disability From Multiple Sclerosis
NEJM 346:158-164,199, Brex,P.A.,et al, 2002
Thrombolysis in Stroke Beyond Three Hours: Targeting Patients With Diffusion and Perfusion MRI
Ann Neurol 51:11-13,28, Warach,S., 2002
The PROGRESS Trial: Preventing Strokes by Lowering Blood Pressure in Patients With Cerebral Ischemia
Stroke 33:319-320, van Gijn,J., 2002
Clinical and Imaging Findings in Cryptogenic Stroke Patients With and Without Patent Foramen Ovale
Stroke 33:706-711, Lamy,C.,et al, 2002
Angiotropic Large Cell Lymphoma with Imaging Characteristics of CNS Vasculitis
AJNR 23:239-242, Song,D.K.,et al, 2002
Diffusion-perfusion MRI Characterization of Post-recanalization Hyperperfusion in Humans
Neurol 57:2015-2021, Kidwell,C.S.,et al, 2001
Acute Stroke Care in Non-urban Emergency Departments
Neurol 57:2006-2012, Burgin,W.S.,et al, 2001
Silent Infarcts in Children With Sickle Cell Anemia and Abnormal Cerebral Artery Velocity
Arch Neurol 58:2017-2021, Pegelow,C.H.,et al, 2001
[123I]Beta-CIT SPECT Imaging Assessment of the Rate of Parkinson's Disease Progression
Neurol 57:2089-2094, Marek,K.,et al, 2001
Randomised Trial of a Perindopril-based Blood-pressure-lowering Regimen Among 6105 Individuals with Previous Stroke or Transient Ischaemic Attack
Lancet 358:1033-1041,1026, PROGRESS Collaborative Group, 2001
Is There an Apparent Diffusion Coefficient Threshold in Predicting Tissue Viability in Hyperacute Stroke?
Stroke 32:2486-2491,2460, Oppenheim,C.,et al, 2001
Positron Emission Tomography in Evaluation of Dementia
JAMA 286:2120-2127,2194, Silverman,D.H.S.,et al, 2001
Intra-Arterial Thrombolysis
Neurol 57:S58-S60, Saver,J.L., 2001
Brain Abscess Due to Listeria Monocytogenes, Five Cases and a Review of the Literature
Medicine 80:223-235, Eckburg,P.B.,et al, 2001
Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated with Intra-Arterial thrombolysis,Prediction of Final Infarct Volume and Clinical Outcome
Stroke 32:2021-2028, Lev,M.H.,et al, 2001
Postpartum Blindness
Lancet 358:1338, Jurgensen,J.S.,et al, 2001
Retinal Microvascular Abnormalities and Incident Stroke: The Atherosclerosis Risk in Communities Study
Lancet 358:1134-1140, Wong,T.Y.,et al, 2001
Evolution of Cerebral Infarct Volume Assessed by Diffusion-Weighted Magnetic Resonance Imaging
Arch Neurol 58:613-617, Lansberg,M.,G.,et al, 2001
Multiple Simultaneous Intracerebral Hemorrhages
Arch Neurol 58:629-632, Maurino,J.,et al, 2001
Diffusion-Weighted Imaging and National Institutes of Health Stroke Scale in the Acute Phase of Posterior-Circulation Stroke
Arch Neurol 58:621-628, Linfante,I.,et al, 2001
Stroke Prevention and Treatment in Sickle Cell Disease
Arch Neurol 58:565-568, Adams,R.J., 2001
Diffusion- and Perfusion -Weighted Brain Magnetic Resonance Imaging in Patients with Neurologic Complications After Cardiac Surgery
Arch Neurol 58:571-576, Wityk,R.J.,et al, 2001
Stroke with Internal Carotid Artery Stenosis
Arch Neurol 58:605-609, Tsiskaridze,A.,et al, 2001
Dysarthria in Acute Ischemic Stroke
Neurol 56:1021-1027, Urban,P.P.,et al, 2001
Asterixis After Unilateral Stroke: Lesion Location of 30 Patients
Neurol 56:533-536, Kim,J.S., 2001
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
NEJM 344:710-719,763, Freed,C.R.,et al, 2001
Clinical and Neuroradiologic Features of Acute Disseminated Encephalomyelitis in Children
Neurol 56:1308-1312,1257, Hynson,J.L.,et al, 2001
Acute Stroke Patterns in Patients With Internal Carotid Artery Disease
Stroke 32:1323-1329, Szabo,K.,et al, 2001
Subclinical Dopaminergic Dysfunction in Asymptomatic Parkinson's Disease Patients' Relatives with a Decreased Sense of Smell
Ann Neurol 50:34-41, Berendse,H.W.,et al, 2001
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1505-1513, Li,D.K.B.,et al, 2001
Relationship Between Magnetic Resonance Arterial Patency and Perfusion-Diffusion Mismatch in Acute Ischemic Stroke and Its Potential Clinical Use
Arch Neurol 58:1069-1074, Staroselskaya,I.A.,et al, 2001
PRISMS-4: Long-Term Efficacy of Interferon-B-1a in Relapsing MS
Neurol 56:1628-1636,1620, The PRISMS Study Group, 2001